Molecular and Cellular Biochemistry

, Volume 384, Issue 1–2, pp 83–94 | Cite as

Platelet-activating factor induces proliferation in differentiated keratinocytes

  • Astrid J. Feuerherm
  • Katarina M. Jørgensen
  • Randi M. Sommerfelt
  • Live E. Eidem
  • Astrid Lægreid
  • Berit JohansenEmail author


Increased levels of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) are found in several inflammatory dermatoses, but PAF’s exact role in epidermis is uncertain. In order to better understand the physiological consequences of excess PAF production in epidermis, we examined the gene regulatory effects of PAF short-term stimulation in differentiated HaCaT keratinocytes by transcriptional profiling. Even though PAF induces COX2 expression, we found that PAF regulates only few genes associated with inflammation in differentiated keratinocytes. Rather, we show that natural PAF rapidly regulates genes involved in proliferation, (anti)-apoptosis and migration, all sub-processes of re-epithelialization and wound healing. Moreover, profiling of phosphorylated kinases, cellular wound-scratch experiments, resazurin assay and flow cytometry cell cycle phase analysis all support a role for PAF in keratinocyte proliferation and epidermal re-epithelialization. In conclusion, these results suggest that PAF acts as an activator of proliferation and may, therefore, function as a connector between inflammation and proliferation in differentiated keratinocytes.


HaCaT Transcriptional profiling Inflammation Wound healing Psoriasis 



Epidermal growth factor


EGF receptor


Mitogen-activated protein kinase


Minimum information about microarray experiment


Platelet-activating factor


Platelet-activating factor receptor


Phospholipase A2



The study was supported financially by the Norwegian Research Council Grant to AJF and the NTNU Medical Technology Program Grant to KMJ. We thank Mari Sæther, Thuy Nguyen, Sjur Huseby, Hans-Richard Brattbakk, Endre Anderssen and Vidar Beisvåg for excellent technical assistance.

Conflict of interest

The authors state no conflict of interest.


  1. 1.
    Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419–445PubMedCrossRefGoogle Scholar
  2. 2.
    Ishii S, Shimizu T (2000) Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39:41–82 PubMedCrossRefGoogle Scholar
  3. 3.
    Walterscheid JP, Ullrich SE, Nghiem DX (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195:171–179PubMedCrossRefGoogle Scholar
  4. 4.
    Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA, Travers JB (1998) Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 273:18891–18897PubMedCrossRefGoogle Scholar
  5. 5.
    Travers J, Murphy R, Johnson C, Pei Y, Morin S, Clay K, Barber L, Hood A, Morelli J, Williams D (1998) Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. Prostaglandins Other Lipid Mediat 56:305–324PubMedCrossRefGoogle Scholar
  6. 6.
    Grandel K, Farr R, Wanderer A, Eisenstadt T, Wasserman S (1985) Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 313:405–409PubMedCrossRefGoogle Scholar
  7. 7.
    Mallet AI, Cunningham FM (1985) Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun 126:192–198PubMedCrossRefGoogle Scholar
  8. 8.
    Okubo K, Karashima T, Hachisuka H, Sasai Y (1989) The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques. Kurume Med J 36:173–179PubMedCrossRefGoogle Scholar
  9. 9.
    Bazan H, Reddy S, Lin N (1991) Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res 52:481–491PubMedCrossRefGoogle Scholar
  10. 10.
    Chandrasekher G, Ma X, Lallier TE, Bazan HEP (2002) Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci 43:1422–1428PubMedGoogle Scholar
  11. 11.
    Owen JS, Baker PR, O’Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL (2005) Stress-induced platelet-activating factor synthesis in human neutrophils. Biochim Biophys Acta 1733:120–129PubMedCrossRefGoogle Scholar
  12. 12.
    Izumi T, Shimizu T (1995) Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1259:317–333PubMedCrossRefGoogle Scholar
  13. 13.
    Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40:643–672PubMedCrossRefGoogle Scholar
  14. 14.
    Marques SA, Dy LC, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB, Spandau DF (2002) The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther 300:1026–1035PubMedCrossRefGoogle Scholar
  15. 15.
    Sato S, Kume K, Ito C, Ishii S, Shimizu T (1999) Accelerated proliferation of epidermal keratinocytes by the transgenic expression of the platelet-activating factor receptor. Arch Dermatol Res 291:614–621PubMedCrossRefGoogle Scholar
  16. 16.
    Shimada A, Ota Y, Sugiyama Y, Sato S, Kume K, Shimizu T, Inoue S (1998) In situ expression of platelet-activating factor (paf)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. J Invest Dermatol 110:889–893PubMedCrossRefGoogle Scholar
  17. 17.
    Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC, Fertel RH, Nguyen TM, Williams DA, Travers JB (1998) Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161:1954–1961PubMedGoogle Scholar
  18. 18.
    Dy LC, Pei Y, Travers JB (1999) Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. J Biol Chem 274:26917–26921PubMedCrossRefGoogle Scholar
  19. 19.
    Travers JB, Edenberg HJ, Zhang Q, Al-Hassani M, Yi Q, Baskaran S, Konger RL (2007) Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J Invest Dermatol 128:455–460PubMedCrossRefGoogle Scholar
  20. 20.
    Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–771PubMedCrossRefGoogle Scholar
  21. 21.
    Travers JB, Huff JC, Rola-Pleszczynski M, Gelfand EW, Morelli JG, Murphy RC (1995) Identification of functional platelet-activating factor receptors on human keratinocytes. J Investig Dermatol 105:816–823PubMedCrossRefGoogle Scholar
  22. 22.
    Jorgensen KM, Felberg HS, Berge RK, Laegreid A, Johansen B (2010) Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. Arch Dermatol Res 302:221–227PubMedCrossRefGoogle Scholar
  23. 23.
    Bruland T, Anderssen E, Doseth B, Bergum H, Beisvag V, Laegreid A (2007) Optimization of cDNA microarrays procedures using criteria that do not rely on external standards. BMC Genomics 8:377PubMedCrossRefGoogle Scholar
  24. 24.
    Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15PubMedCrossRefGoogle Scholar
  25. 25.
    Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3(1):3Google Scholar
  26. 26.
    Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodol) 57:289–300Google Scholar
  27. 27.
    Huang DW, Sherman BT, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRefGoogle Scholar
  28. 28.
    Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW (2000) Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285:194–204PubMedCrossRefGoogle Scholar
  29. 29.
    Levan TD, Bloom JW, Adams DG, Hensel JL, Halonen M (1998) Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. Mol Pharmacol 53:135–140PubMedGoogle Scholar
  30. 30.
    Cellai C, Laurenzana A, Vannucchi AM, Caporale R, Paglierani M, Di Lollo S, Pancrazzi A, Paoletti F (2006) Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. Br J Cancer 94:1637–1642PubMedGoogle Scholar
  31. 31.
    Lemaître G, Lamartine J, Pitaval A, Vaigot P, Garin J, Bouet S, Petat C, Soularue P, Gidrol X, Martin MT, Waksman G (2004) Expression profiling of genes and proteins in HaCaT keratinocytes: proliferating versus differentiated state. J Cell Biochem 93:1048–1062PubMedCrossRefGoogle Scholar
  32. 32.
    Kume K, Shimizu T (1997) Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor. J Biol Chem 272:22898–22904PubMedCrossRefGoogle Scholar
  33. 33.
    Neub A, Houdek P, Ohnemus U, Moll I, Brandner JM (2007) Biphasic regulation of AP-1 subunits during human epidermal wound healing. J Invest Dermatol 127:2453–2462PubMedCrossRefGoogle Scholar
  34. 34.
    Lam MH, Olsen SL, Rankin WA, Ho PW, Martin TJ, Gillespie MT, Moseley JM (1997) PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J Cell Physiol 173:433–446PubMedCrossRefGoogle Scholar
  35. 35.
    Ramos G, Kazimi N, Nghiem DX, Walterscheid JP, Ullrich SE (2004) Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. Toxicol Appl Pharmacol 195:331–338PubMedCrossRefGoogle Scholar
  36. 36.
    Rundhaug JE, Simper MS, Surh I, Fischer SM (2011) The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev 30:465–480PubMedCrossRefGoogle Scholar
  37. 37.
    Reichel CA, Rehberg M, Lerchenberger M, Berberich N, Bihari P, Khandoga AG, Zahler S, Krombach F (2009) Ccl2 and Ccl3 mediate neutrophil recruitment via induction of protein synthesis and generation of lipid mediators. Arterioscler Thromb Vasc Biol 29:1787–1793PubMedCrossRefGoogle Scholar
  38. 38.
    Hacke K, Rincon-Orozco B, Buchwalter G, Siehler SY, Wasylyk B, Wiesmuller L, Rosl F (2010) Regulation of MCP-1 chemokine transcription by p53. Mol Cancer 9:82PubMedCrossRefGoogle Scholar
  39. 39.
    Sahu RP, Kozman AA, Yao Y, DaSilva SC, Rezania S, Martel KC, Warren SJ, Travers JB, Konger RL (2012) Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. Carcinogenesis 33:694–701 PubMedCrossRefGoogle Scholar
  40. 40.
    Dietrich C, Scherwat J, Faust D, Oesch F (2002) Subcellular localization of beta-catenin is regulated by cell density. Biochem Biophys Res Commun 292:195–199PubMedCrossRefGoogle Scholar
  41. 41.
    Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R (2010) p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 31:1501–1508PubMedCrossRefGoogle Scholar
  42. 42.
    Toledo F, Wahl GM (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6:909–923PubMedCrossRefGoogle Scholar
  43. 43.
    Im HJ, Pittelkow MR, Kumar R (2002) Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1. J Biol Chem 277:14612–14621PubMedCrossRefGoogle Scholar
  44. 44.
    Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M (1999) The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol Cell Biol 19:2594–2600PubMedGoogle Scholar
  45. 45.
    Zou Z, Gao C, Nagaich AK, Connell T, Saito SI, Moul JW, Seth P, Appella E, Srivastava S (2000) p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275:6051–6054PubMedCrossRefGoogle Scholar
  46. 46.
    Rozan LM, El-Deiry WS (2006) Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target. Cancer Biol Ther 5:1228–1235PubMedCrossRefGoogle Scholar
  47. 47.
    Saha AK, Persons K, Safer JD, Luo Z, Holick MF, Ruderman NB (2006) AMPK regulation of the growth of cultured human keratinocytes. Biochem Biophys Res Commun 349:519–524PubMedCrossRefGoogle Scholar
  48. 48.
    Kishi K, Yuasa T, Minami A, Yamada M, Hagi A, Hayashi H, Kemp BE, Witters LA, Ebina Y (2000) AMP-activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem Biophys Res Commun 276:16–22PubMedCrossRefGoogle Scholar
  49. 49.
    Muller EJ, Williamson L, Kolly C, Suter MM (2008) Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol 128:501–516PubMedCrossRefGoogle Scholar
  50. 50.
    Lu J, Caplan MS, Li D, Jilling T (2008) Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294:G1181–G1190PubMedCrossRefGoogle Scholar
  51. 51.
    Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1–14PubMedCrossRefGoogle Scholar
  52. 52.
    Lukashova V, Asselin C, Krolewski JJ, Rola-Pleszczynski M, Stankova J (2001) G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. J Biol Chem 276:24113–24121PubMedCrossRefGoogle Scholar
  53. 53.
    Deo DD, Bazan NG, Hunt JD (2004) Activation of platelet-activating factor receptor-coupled G alpha q leads to stimulation of Src and focal adhesion kinase via two separate pathways in human umbilical vein endothelial cells. J Biol Chem 279:3497–3508PubMedCrossRefGoogle Scholar
  54. 54.
    Bhalla US, Iyengar R (2001) Robustness of the bistable behavior of a biological signaling feedback loop. Chaos 11:221–226PubMedCrossRefGoogle Scholar
  55. 55.
    Oestvang J, Anthonsen MW, Johansen B (2011) LysoPC and PAF trigger arachidonic acid release by divergent signaling mechanisms in monocytes. J Lipids 2011:532145PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Astrid J. Feuerherm
    • 1
  • Katarina M. Jørgensen
    • 1
  • Randi M. Sommerfelt
    • 1
  • Live E. Eidem
    • 1
  • Astrid Lægreid
    • 2
  • Berit Johansen
    • 1
    Email author
  1. 1.Department of BiologyNorwegian University of Science and Technology (NTNU)TrondheimNorway
  2. 2.Department of Cancer Research and Molecular MedicineNorwegian University of Science and Technology (NTNU)TrondheimNorway

Personalised recommendations